In the ACC, there was a statistically significant increase of mRNA expression level of GFAP in the patients with BPD compared to controls (p = 0.018), whereas a trend for a decrease was observed in the subjects with MDD compared to controls (p = 0.076, Figure 1A). This evidence concerns the gene GFAP and major depressive disorder.